Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein cysteine residues in redox-sensitive signaling proteins serve as critical sensors for cellular oxidative stress and electrophilic signals [6, 12]. These specific residues often exhibit a lowered pKa, allowing them to exist as reactive thiolate anions at physiological pH, which facilitates post-translational modifications such as S-nitrosylation, S-glutathionylation, and disulfide formation [9, 10]. Such modifications act as "thiol switches" that regulate the activity of key proteins, including transcription factors like Nrf2 and NF-κB, as well as various protein kinases and phosphatases [8, 11, 14]. In many pathological states, including cancer and chronic inflammation, the redox balance is disrupted, leading to aberrant signaling through these cysteine-mediated pathways [1, 11]. Modern drug discovery increasingly exploits these reactive sites through the design of covalent inhibitors (e.g., afatinib, sotorasib) that specifically target a cysteine residue within a binding pocket to achieve high potency and prolonged duration of action [1, 4]. However, the inherent reactivity of these residues necessitates careful design to avoid widespread off-target effects and potential immunogenicity [1, 4].
Covalent modification of reactive thiol groups (thiolates) to modulate protein activity, stability, or signaling.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein cysteine residues in redox-sensitive signaling proteins.